Abiopharma

Salesforce Signs Definitive Agreement to Acquire Fin

Fiserv Announces Leadership Transition

Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway

Chase Freedom® Announces Q3 2026 5% Cash Back Categories: Gas Stations and EV Charging, Public Transit, Select Live Entertainment and United Way

Meeting on 18.6.26 – removal of items 7 and 8 from the agenda of the meeting, for the purpose of exhausting discussions with the staff of the Israel Securities Authority and with institutional bodies.

Alto Neuroscience, Inc. - Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia

Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia

AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency

Preclinical Data for OPKO Biologics OPK8801001 in Acromegaly Presented at ENDO 2026

Wabash Partners with Transport Trailer Sales Inc. to Expand Canadian Dealer Network